Table 1.
Strain (and source) | Mutations | Advantages | Refs |
---|---|---|---|
NOD background | Reduced NK cells and C5a function, increased binding of NOD SIRPα to human CD47, which reduces macrophage phagocytosis | [[106], [107], [108]] | |
NOD.scid (Jax 001303, Tac NODSC, CRL 394) | Prkdcnull (scid) | T- and B-cell deficiency | [106] |
NOD.RagKO (Jax 003729) | Rag1null | ||
NSG (Jax 005557) |
Prkdcnull (scid) Il2rgnull |
Eliminates any residual NK and lymphocyte activity | [109] |
NOG (Tac NOG) | |||
NCG (CRL 572) | |||
NRG (Jax 007799) | Rag1nullIl2rgnull | [110] | |
NRG-NFA2 (Jax 033127) |
Rag1nullIl2rgnull Flt3null |
Impaired murine myeloid cell development | [111] |
NBSGW (Jax 026622) |
Prkdcnull (scid) Il2rgnullKitW41 |
Mutation in the mouse Kit gene limits hematopoiesis, providing an advantage to donor cells, and circumvents the need for irradiation | [112] |
NSGW41 (Inq) | [113] | ||
NSG.MHC-I/II−/- (Jax 030547) |
Prkdcnull (scid) Il2rgnullB2mnull(IA IE)null |
Prevention of xenogeneic reactivity of human immune cells | [114] |
NOG.MHC-I/II−/- (Inq) | [115] | ||
BALB/c background | |||
BRG (Tac 11503) | Rag2nullIl2rgnull | Same as NSG, but less frequently used. | [116] |
BRGS (GenOway) |
Rag2nullIl2rgnull SirpaNOD |
Same as BRG, with reduced murine macrophage phagocytosis | [117] |
BRGSF (GenOway) |
Rag2nullIl2rgnull SirpaNODFlk2null |
Same as BRGS, with reduced myeloid cell compartment | [118] |
C57BL/6 background | |||
B6RGS (Inq) |
Rag2nullIl2rgnull SirpaNOD |
Same as BRG, with reduced murine macrophage phagocytosis | [119] |
BRAGG47 (Jax 032088) |
Rag1nullIl2rgnull CD47null |
Phagocytes developing in this strain are more tolerant to transplanted human cells (B6 mice) | [120] |